| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5269464
Max Phase: Preclinical
Molecular Formula: C27H24N6O3
Molecular Weight: 480.53
Associated Items:
Representations
Canonical SMILES: N=C(N)c1ccc(Oc2cc(Oc3ccc(C(=N)N)cc3)cc(Oc3ccc(C(=N)N)cc3)c2)cc1
Standard InChI: InChI=1S/C27H24N6O3/c28-25(29)16-1-7-19(8-2-16)34-22-13-23(35-20-9-3-17(4-10-20)26(30)31)15-24(14-22)36-21-11-5-18(6-12-21)27(32)33/h1-15H,(H3,28,29)(H3,30,31)(H3,32,33)
Standard InChI Key: FJZLYGDCIBSPGQ-UHFFFAOYSA-N
Associated Targets(Human)
Matriptase 677 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 480.53 | Molecular Weight (Monoisotopic): 480.1910 | AlogP: 4.92 | #Rotatable Bonds: 9 |
| Polar Surface Area: 177.30 | Molecular Species: BASE | HBA: 6 | HBD: 6 |
| #RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: 12.15 | CX LogP: 3.24 | CX LogD: -3.99 |
| Aromatic Rings: 4 | Heavy Atoms: 36 | QED Weighted: 0.15 | Np Likeness Score: -0.06 |
References
| 1. Hammerschmidt SJ, Maus H, Weldert AC, Gütschow M, Kersten C.. (2023) Improving binding entropy by higher ligand symmetry? - A case study with human matriptase., 14 (5): [PMID:37252099] [10.1039/d3md00125c] |
Source
Source(1):